Loading clinical trials...
Loading clinical trials...
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Conditions
Interventions
BKM120
Locations
42
United States
St. Joseph's Hospital & Medical Center St Joseph's
Phoenix, Arizona, United States
Highlands Oncology Group Dept of Highlands Oncology Grp
Fayetteville, Arkansas, United States
Morristown Memorial Hospital MMH
Morristown, New Jersey, United States
Carolinas HealthCare Systems Blumenthal Cancer Center
Charlotte, North Carolina, United States
University of Oklahoma Health Sciences Center OU Health
Oklahoma City, Oklahoma, United States
Sarah Cannon Research Institute SCRI (2)
Nashville, Tennessee, United States
Start Date
February 1, 2011
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
May 30, 2019
NCT05112991
NCT06584032
NCT05077215
NCT01379534
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions